Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 15 6 2022
medline: 15 11 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Pharmacokinetics of cyclophosphamide has been explored to optimize conditioning dosing. We hypothesized that post-transplant cyclophosphamide (PTCy) metabolite carboxy-ethyl phosphoramide mustard (CEPM) pharmacokinetics might impact haploidentical transplantation (haplo-HCT) outcomes. CEPM area under the curve (AUC

Identifiants

pubmed: 35699967
doi: 10.1080/10428194.2022.2087067
doi:

Substances chimiques

Cyclophosphamide 8N3DW7272P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2679-2685

Auteurs

Kripa Shanker Kasudhan (KS)

Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Amol N Patil (AN)

Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Aditya Jandial (A)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Alka Khadwal (A)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Gaurav Prakash (G)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Arihant Jain (A)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Dinesh Bhurani (D)

Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Rayaz Ahmed (R)

Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Narendra Agrawal (N)

Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Reema Singh (R)

Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Man Updesh Singh Sachdeva (MUS)

Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Neelam Varma (N)

Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Reena Das (R)

Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Savita Verma Attri (S)

Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Samir Malhotra (S)

Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Navneet S Majhail (NS)

Blood and Marrow Transplant Program, Department of Hematology-Oncology, Cleveland Clinic, Cleveland, OH, USA.

Pankaj Malhotra (P)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Deepesh P Lad (DP)

Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH